Opko Health Inc (OPK)

[DegenerateGambler]

Yes, the Rayaldee trials are coming and the growth hormone has potential, but even if the trials are successful this horse is far behind in the race. There are too many big drug companies with better products that will likely be on the market far ahead of Rayaldee. It is still possible Rayaldee will give the Opko share price a shot in the are but it may be too little too late. The growth hormone has a better chance, but when.
The biggest problem is all the other companies are coming up with fastest and better tests for COVID that will very likely reduce BRL sales and contract renewals in the near future. BRL has been carrying Opko with its strong revenues that will soon be reduced. I now like Thermo Fisher and Qiagen in the testing industry as they both will dominate BRL. The best thing Frost could do now is sell BRL when it’s looking so good on paper.
In any event, for all the above reasons I sold my shares at $3.74 to invest in the other testing company. I don’t doubt that someday Opko will be a great investment, but I right now QGEN and TMO look a lot better to me at this point in time. I wish the best to all the longs here, and hope they squeeze out the shorts.